These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6995540)

  • 1. Prostaglandin E1 therapy of murine chronic serum sickness.
    McLeish KR; Gohara AF; Gunning WT; Senitzer D
    J Lab Clin Med; 1980 Sep; 96(3):470-9. PubMed ID: 6995540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of antibody synthesis by prostaglandin E as a mechanism for preventing murine immune complex glomerulonephritis.
    McLeish KR; Gohara AF; Gunning WT
    Lab Invest; 1982 Aug; 47(2):147-52. PubMed ID: 6213813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
    McLeish KR; Stelzer GT; Eades DS; Cohen R; Wallace JH
    J Lab Clin Med; 1985 Nov; 106(5):517-23. PubMed ID: 2932513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of H-2 in apoferritin-induced murine immune complex glomerulonephritis.
    Frymoyer PA; Tatum AH; Hajdu I
    Lab Invest; 1988 Jun; 58(6):674-81. PubMed ID: 3379915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic serum sickness in the mouse. Relationship of antigen dose to glomerular pathology.
    McLeish KR; Gohara AF; Gunning WT
    Nephron; 1982; 31(1):82-8. PubMed ID: 6213878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of murine immune complex glomerulonephritis with prostaglandin E2: dose--response of immune complex deposition, antibody synthesis, and glomerular damage.
    McLeish KR; Gohara AF; Stelzer GT; Wallace JH
    Clin Immunol Immunopathol; 1983 Jan; 26(1):18-23. PubMed ID: 6575881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complex acute necrotizing glomerulonephritis with progression to diffuse glomerulosclerosis. A murine model.
    Iskandar SS; Gifford DR; Emancipator SN
    Lab Invest; 1988 Dec; 59(6):772-9. PubMed ID: 2974100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstrain variations in nephritogenicity of heterologous protein in mice.
    Iskandar SS; Jennette JC; Wilkman AS; Becker RL
    Lab Invest; 1982 Mar; 46(3):344-51. PubMed ID: 6460898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on experimental immune complex nephritis (3). Therapeutic effect of prostaglandin E1 alpha-cyclodextrin host molecule (PGE1 . CD) on serum sickness nephritis in rats.
    Nagamatsu T; Saitoh N; Suzuki Y; Ikuta K; Aoki S
    Jpn J Pharmacol; 1984 Aug; 35(4):407-14. PubMed ID: 6239050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
    Cruse JM; Lewis RE; Dilioglou S
    Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prostaglandin E on immune complex nephritis in NZB/W mice.
    Kelley VE; Winkelstein A; Izui S
    Lab Invest; 1979 Dec; 41(6):531-7. PubMed ID: 159978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephritogenicity and differential distribution of glomerular immune complexes related to immunogen charge.
    Gallo GR; Caulin-Glaser T; Emancipator SN; Lamm ME
    Lab Invest; 1983 Mar; 48(3):353-62. PubMed ID: 6338294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration in immune complex glomerulonephritis by arachidonic acid.
    McLeish KR; Gohara AF; Johnson LJ; Sustarsic DL
    Prostaglandins; 1982 Mar; 23(3):383-9. PubMed ID: 6808591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenomegaly and immune complex splenitis in rabbits with experimentally induced chronic serum sickness: immunopathological findings.
    Albini B; Ito S; Brentjens J; Andres G
    J Reticuloendothel Soc; 1983 Dec; 34(6):485-500. PubMed ID: 6361254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesangial disposal of glomerular immune deposits in acute malarial glomerulonephritis of rats.
    Sterzel RB; Ehrich JH; Lucia H; Thomson D; Kashgarian M
    Lab Invest; 1982 Feb; 46(2):209-14. PubMed ID: 7038293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction of chronic antigen-antibody complex disease in selectively bred mice producing either high or low affinity antibody to protein antigens.
    Devey ME; Steward MW
    Immunology; 1980 Oct; 41(2):303-11. PubMed ID: 6449473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired mesangial clearance of macromolecules in rats with chronic mesangial ferritin-antiferritin immune complex deposition.
    Keane WF; Raij L
    Lab Invest; 1980 Dec; 43(6):500-8. PubMed ID: 7442126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice.
    Le Hir M; Haas C; Marino M; Ryffel B
    Lab Invest; 1998 Dec; 78(12):1625-31. PubMed ID: 9881962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody.
    Ravirajan CT; Wang Y; Matis LA; Papadaki L; Griffiths MH; Latchman DS; Isenberg DA
    Rheumatology (Oxford); 2004 Apr; 43(4):442-7. PubMed ID: 15024133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
    Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
    Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.